The board of directors of Hospital Corporation of China Limited announced that with effect from June 23, 2020, (i) Mr. SHAN Guoxin ("Mr. Shan") has resigned as an executive Director, the chief executive officer of the Company ("Chief Executive Officer"), a member of the remuneration committee of the Company ("Remuneration Committee") and an authorised representative of the Company ("Authorised Representative") under Rule 3.05 of the Rules (the "Listing Rules") Governing the Listing of Securities on The Stock Exchange of Hong Kong Limited ("HKEX") for personal development reasons; (ii) Mr. ZHAO John Huan ("Mr. Zhao") has resigned as a non-executive Director, the chairman of the Board and the chairman of the nomination committee of the Company ("Nomination Committee") due to work arrangements; and (iii) Mr. LI Peng ("Mr. Li") has resigned as a non-executive Director and a member of the audit committee of the Company ("Audit Committee") due to work arrangements. The Board further announces that with effect from June 23, 2020, (i) Mr. SU Zhiqiang ("Mr. Su") has been appointed as an executive Director, a member of the Remuneration Committee and an Authorised Representative; (ii) Mr. CHEN Shuai ("Mr. Chen") has been appointed as a non-executive Director, the chairman of the Board, the acting Chief Executive Officer and the chairman of the Nomination Committee; and (iii) Ms. SHI Wenting ("Ms. Shi") has been appointed as a non-executive Director and a member of the Audit Committee.